Delivery Order SPE2DX22D0010-SPE2D825FHV82
Award Date 8/22/25
Potential Completion Date 8/25/25
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,392.96 contract is for the delivery of Zenzedi (dextroamphetamine) 15mg tablets, a prescription medication. The contract has an ultimate completion date of July 7, 2025 and is not a set-aside award. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zenzedi Tablets 20mg, a pharmaceutical product, with a ceiling value of $5,523.42 and a period of performance ending on April 15, 2025. The contract is not set-aside and was awarded on April 14, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $2,943.88 by the Defense Logistics Agency's Medical Supply Chain for the supply of ADZENYS XR ODT (orally disintegrating tablets) 6.3mg pharmaceutical product. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed pricing under a competitive award with no set-aside designation. The place of performance is listed as the vendor's corporate office location in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lisdexamfetamine capsules 30mg, with a ceiling value of $4,474.11. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is due for completion by August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) valued at $4,498.98. This competitive award (no set-aside used) is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepzelca 4 mg vials, with a ceiling value of $9,565.56 and a firm fixed price structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 3, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role...
- This delivery order, awarded on August 18, 2025, represents a competitively awarded, firm fixed-price contract for pharmaceutical supplies valued at $9,107.57. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected to supply Adzenys XR ODT tablets (1's, 18.8mg), a medication used in the treatment of attention-deficit/hyperactivity disorder. The contract is classified as a non-set-aside award and carries an ultimate completion...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,073.53 delivery order to AmerisourceBergen Drug Corp for 100 units of dextroamphetamine extended-release 30mg tablets. The contract was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and utilized firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,189.40. This firm fixed-price delivery order, which is not set-aside, represents a competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- This federal contract award is for the delivery of Adzenys XR ODT tabs 1's 15.7mg to the Medical Supply Chain unit of the Defense Logistics Agency (DLA), a defense agency. The $2,499.64 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of October 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...